Valuation: Ovation Science Inc.

Market Cap 11.53L 8L 7L 7L 6L 7.79Cr 11.65L 81.37L 31.36L 3.98Cr 30.5L 29.84L 13Cr P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 13.64L 10L 8L 8L 7L 9.22Cr 13.77L 96.24L 37.09L 4.71Cr 36.08L 35.29L 15Cr EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.56%
Yield 2024 *
-
Yield 2025 -
1 day+50.00%
3 months+100.00%
Current year-25.00%
1 month 0.02
Extreme 0.02
0.03
Current year 0.02
Extreme 0.015
0.04
1 year 0.02
Extreme 0.015
0.05
3 years 0.01
Extreme 0.01
0.08
5 years 0.01
Extreme 0.01
0.11
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Director of Finance/CFO 63 30/10/2023
Chief Executive Officer 77 04/10/2017
Director TitleAgeSince
Director/Board Member 77 04/10/2017
Director/Board Member 63 04/10/2017
Director/Board Member 86 02/02/2018
Date Insider Type Main position Quantity % Market Cap. Importance
07/04/25 Buy

Director

1,00,000 0.2642%
31/01/25 Other

Director

0 0%
31/01/25 Buy

Director

1,00,000 0.2642%
Change 5-day change 1-year change 3-year change Capi.($)
+50.00%0.00%-14.29%0.00% 8L
-1.10%-0.79%+3.77%-2.45% 23TCr
+2.38%+2.85%+22.49% - 4.54TCr
-1.63%-0.96%+61.11% - 1.01TCr
-3.18%-4.10%+35.11%-35.16% 895.46Cr
0.00%-1.59%+16.58%+16.97% 645.18Cr
-0.10%-0.41%-22.48%-7.40% 600.7Cr
-2.42%-2.71%+14.81%-14.33% 377.71Cr
-1.28%-5.12%-33.63%-46.87% 319.05Cr
-0.20%+1.14%+9.49%-26.54% 302.48Cr
Average +4.09%+0.29%+9.30%-14.47% 3.2TCr
Weighted average by Cap. -0.82%+0.30%+8.70%-4.17%

Financials

2024 2025
Net sales 1L 79.75T 70.38T 66.59T 60.39T 76.52L 1L 8L 3L 39.08L 3L 3L 1.26Cr 67.89T 47.82T 42.2T 39.93T 36.21T 45.88L 68.56T 5L 2L 23.43L 2L 2L 75.4L
Net income -5L -3L -3L -3L -2L -3.08Cr -5L -32.19L -12.41L -1.57Cr -12.07L -11.8L -5.07Cr -6L -4L -4L -4L -3L -4.27Cr -6L -44.54L -17.17L -2.18Cr -16.7L -16.33L -7.01Cr
Net Debt 3L 2L 2L 2L 1L 1.79Cr 3L 18.71L 7L 91.52L 7L 7L 2.95Cr 2L 1L 1L 1L 1L 1.42Cr 2L 14.87L 6L 72.75L 6L 5L 2.34Cr
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. OVAT Stock